2,354 material Form 8-K filings that 2,004 companies we cover made with the SEC in November 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 1,081 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Marcus & Millichap reported third quarter 2026 revenue of $208.4 million, up 7.5% from a year earlier, and net income of $1.0 million, or $0.03 per diluted share, compared with $0.2 million, or $0.01, in the third quarter of 2025. The company said the results are preliminary until it files its Form 10-Q, and it expects near-term challenges in the commercial real estate market to extend through 2026.
Total revenue was $208.4 million versus $193.9 million; brokerage commissions rose 7.4% to $174.1 million, with Middle Market and Larger Transaction Market brokerage revenue up 18.1%.
Adjusted EBITDA was $8.2 million versus $6.9 million; cost of services rose to 64.0% of total revenue, up 160 basis points.
Nine-month revenue was $582.8 million, up 14.0%, and nine-month net income was $1.8 million, or $0.05 per diluted share, compared with a net loss of $15.2 million.
The company repurchased 912,957 shares for $23.9 million in the first nine months and had about $90.1 million remaining under its repurchase program as of November 3, 2026.
Align Technology entered an accelerated share repurchase agreement with Goldman Sachs to buy back $270 million of its common stock, funded with cash on hand. The company expects to complete the transaction by about December 29, 2026, and says the deal brings its total 2026 share repurchases to approximately $500 million.
ASR of $270 million, with a $270 million prepayment to Goldman Sachs made under the agreement dated November 5, 2026
Initial delivery of approximately 1.44 million shares; final share count depends on volume-weighted average price less a discount
Approximately $330 million remains under the $1.0 billion repurchase program after this transaction; cash and equivalents were about $1.145 billion as of September 30, 2026
Final settlement expected no later than about December 29, 2026
Ziff Davis reported unaudited third quarter 2026 results, with revenue down 5.6% from a year earlier and a swing to an operating loss of $33.6 million, including a $29.6 million goodwill impairment. Adjusted diluted EPS was $1.39 versus $1.40 a year earlier, and the company repurchased $92.0 million of its shares during the quarter. The company will discuss the results on a call on November 6, 2026.
Revenue was $289.3 million versus $306.5 million in Q3 2025; adjusted EBITDA was $82.2 million versus $97.8 million.
Net loss from continuing operations was $28.7 million, or $0.85 per diluted share, compared with a loss of $16.0 million, or $0.39 per share, in Q3 2025.
Adjusted diluted EPS was $1.39 compared with $1.40 a year earlier.
Share repurchases totaled $92.0 million in Q3 2026 and approximately $265 million for the first three quarters of 2026.
During its Investor Day on November 5, 2026, Veeva Systems announced it expects its third quarter of fiscal year 2027 results to meet or exceed the preliminary guidance previously provided on August 26, 2026. Chief Financial Officer Brian Van Wagener presented slides detailing expected financial metrics including total revenue of $932 million to $935 million.
Total revenue is expected to be $932 million to $935 million, with subscription revenue at approximately $782 million.
Non-GAAP operating income is projected at $417 million to $420 million, with non-GAAP fully diluted net income per share of $2.33 to $2.34.
The Investor Day presentation and guidance update took place on November 5, 2026.
TKO Group Holdings priced a $1.0 billion offering of 6.500% Senior Secured Notes due 2031, issued by its indirect subsidiary TKO Worldwide Holdings, LLC. The company said net proceeds may fund general corporate purposes, including distributions to parent entities to fund share repurchases under its existing program. The offering adds $1.0 billion of secured debt, which shareholders may weigh against the planned buybacks.
Pricing announced November 5, 2026: $1.0 billion aggregate principal amount of 6.500% Senior Secured Notes due 2031
Issuer is indirect subsidiary TKO Worldwide Holdings, LLC; notes guaranteed by TKO Guarantor, LLC and certain subsidiaries
Proceeds may fund share repurchases under TKO's previously announced program, plus fees and expenses
Closing expected on or about November 13, 2026, subject to customary conditions
Kinder Morgan announced it will post an updated investor presentation on its website by 6:00 a.m. Central Time on November 6, 2026. The filing contains no financial results, guidance, or other figures, so it does not by itself report a change in the company's business.
Updated investor presentation to be posted by 6:00 a.m. Central Time on November 6, 2026
Materials available at ir.kindermorgan.com/presentations-webcasts
Filing is furnished under Item 7.01 and does not state specific financial figures
Revelation Biosciences reported results for the three and nine months ended September 30, 2026, with no revenue line in the filing. The net loss grew from a year earlier, and cash fell from $10.7 million at December 31, 2025 to $9.1 million, which the company says will fund operations into the second quarter of 2027.
Net loss for the three months ended September 30, 2026 was $3.3 million, compared with $1.9 million a year earlier.
Net loss for the nine months ended September 30, 2026 was $9.6 million, compared with $6.4 million a year earlier.
Cash and cash equivalents were $9.1 million at September 30, 2026, versus $10.7 million at December 31, 2025; the company expects this to fund operations into the second quarter of 2027.
Net cash used for operating activities was $2.6 million for the third quarter of 2026, compared with $1.6 million in the same period of 2025.
Parabolic Technologies, Inc. (Nasdaq: PARA) closed a $13.5 million underwritten public offering on November 5, 2026, selling units that each include one share or a pre-funded warrant plus two warrants. The filing says net proceeds were approximately $5.512 million, and the warrants include exercise-price resets that can increase the number of shares issuable, which could dilute existing shareholders.
Gross proceeds of about $13.5 million from 4,963,235 units priced at $2.72 each, with net proceeds of about $5.512 million after offering expenses
Each unit includes two warrants with an initial exercise price of $6.80 per share, for up to 9,926,470 warrant shares
Warrants reset on the fifth and tenth trading days after issuance to the lower of the then-current exercise price and 80% of the lowest VWAP in the measurement period, subject to floor prices, and holders keep additional shares from resets
Aegis Capital Corp. holds a 45-day over-allotment option, and the Underwriter exercised it for 360,000 warrants on November 5, 2026
Avalanche Treasury Corp (AVAT) reported preliminary, unaudited third-quarter 2026 net income of approximately $54.6 million, or $1.53 per diluted share, with about $60 million from market-driven changes in the value of its AVAX holdings and realized losses. It also repurchased about 8% of its Class A shares at an average price of $1.14 and repaid its FalconX loan in full, and the full third-quarter results are due in November 2026.
Preliminary Q3 2026 net income of approximately $54.6 million, or $1.53 per diluted share; approximately $60 million of gains from market-driven changes in AVAX value and realized losses
Repurchased 2,889,440 Class A shares at an average of $1.14 per share, about $3.3 million in total, roughly 8% of Class A shares outstanding as of August 24, 2026
Held 13.31 million AVAX tokens as of September 30, 2026, with about 60% unlocked; about 91% was staked in September 2026
Conference call on November 19, 2026 at 4:00 p.m. ET to discuss third-quarter results
Annovis Bio agreed on November 5, 2026 to sell 19,000,000 shares of common stock (or pre-funded warrants in lieu of shares) with accompanying warrants, with expected gross proceeds of approximately $21.0 million before underwriting discounts and expenses. The offering adds shares and warrants that could dilute existing shareholders, while the company plans to use the proceeds for clinical development of buntanetap and working capital.
Offering of 19,000,000 shares plus pre-funded warrants for up to 2,000,000 shares, with accompanying warrants for up to 21,000,000 shares, priced at $1.00 per share and accompanying warrant
Accompanying warrants are exercisable at $1.00 per share and expire five years after issuance
One of the company's directors is buying 5,000,000 shares and accompanying warrants for $5,000,000
Offering is expected to close on or about November 6, 2026, with Canaccord Genuity LLC as underwriter
Algorhythm Holdings' CEO and Chairman Andrew Thompson resigned effective immediately, with the board stating no disagreement over operations, policies or practices. Director Gregory D. Smith was appointed to both roles on November 2, 2026, under a CEO agreement with a base salary of $375,000 rising to $480,000 on performance conditions.
Andrew Thompson resigned as CEO and Chairman, accepted by the board on October 30, 2026.
Gregory D. Smith, age 67 and a board member since September 2026, became CEO and Chairman on November 2, 2026.
Smith's agreement provides a 2,119,542-share restricted stock award, with 1,059,771 shares vesting immediately and 1,059,771 vesting on the first anniversary of the effective date.
Severance equals two times base salary plus maximum annual bonus; the filing reports 40,848,979 common shares outstanding as of November 4, 2026.
Datavault AI's board removed Nathaniel Bradley as Chief Executive Officer and President and terminated his employment, effective immediately, on November 1, 2026. The action was approved by all directors except Mr. Bradley, who voted against it, and he continues to serve as a board member. The filing does not name a successor or an interim leader, leaving the company's top executive role open as of the filing date.
Removal effective November 1, 2026, with employment terminated immediately
Board action approved by all directors other than Mr. Bradley, who voted against it
Mr. Bradley remains a board member until the next annual meeting or earlier resignation or removal
Mount Logan Capital reported third-quarter 2026 total revenues of $12.9 million, up 12% from $11.4 million a year earlier, and a net loss of $3.7 million versus $13.4 million in the third quarter of 2025. Basic loss per share was $0.33, compared with $1.64, and the company attributed the narrower loss mainly to transaction expenses from the prior-year TURN merger that did not recur. Segment Income fell to $3.2 million in the quarter, but year-to-date Segment Income rose 21% to $11.5 million.
Total revenues $12.9 million for Q3 2026, up 12% from $11.4 million in Q3 2025
Net loss $3.7 million, compared with $13.4 million in Q3 2025; basic loss per share $0.33 versus $1.64
Q3 Segment Income $3.2 million versus $4.2 million; year-to-date Segment Income $11.5 million, up 21%
Quarterly distribution of $0.03 per share payable November 30, 2026 to holders of record on November 19, 2026
On November 2, 2026, Public Policy Holding Company, Inc. (PPHC) entered a $105 million senior secured credit facility with Bank of America, N.A. as administrative agent, and used it to repay and terminate its existing credit agreement. The facility consists of a $65 million term loan and a $40 million revolving credit facility, maturing November 2, 2031, and the company says proceeds will also fund the Reevemark acquisition and working capital.
Facility of $105 million: a $65 million term loan and a $40 million revolving credit facility, maturing November 2, 2031
$65 million was borrowed under the term loan at closing
Interest is SOFR plus 185 to 230 basis points, set by net leverage; the company plans syndication to $150 million, expected to close January 2027 on a best-efforts basis
Existing credit agreement dated February 28, 2023 was repaid and terminated
Comstock reported third-quarter 2026 revenue of $17.9 million, up 34% from a year earlier, and net income of $0.6 million, up 9%. Adjusted EBITDA more than doubled to $2.3 million, although the quarter included a $1.0 million unrealized loss on its Jericho Energy Ventures equity investments. Headline revenue and profit measures improved for both the quarter and the first nine months, but the quarter's net income absorbed that investment loss.
Q3 2026 revenue was $17.9 million versus $13.3 million in Q3 2025; Adjusted EBITDA was $2.3 million versus $1.1 million.
Q3 diluted EPS was $0.06 versus $0.05; year-to-date diluted EPS was $1.05 versus $0.34, with year-to-date net income of $11.4 million.
Q3 net income includes a $1.0 million unrealized loss on Jericho (JEV) equity investments, which partially reverses a significant Q2 gain; the year-to-date gain remains up $3.7 million.
Managed portfolio grew to 115 assets, up from 91 a year earlier, including 12 new ParkX contracts in Q3.
Powerus Corporation provided a business and pipeline update, stating it has executed purchase orders and contracts representing projected revenue of $130 million, expected to be recognized within the next 12 months. It also estimated an unweighted revenue pipeline of about $4.5 billion and a weighted pipeline of $334 million. The filing is informational under Regulation FD and gives no prior-period comparison or guidance, and it warns that pipeline figures are not backlog, revenue, or a forecast.
Executed purchase orders and contracts represent projected revenue of $130 million as of November 5, 2026, expected to be recognized within 12 months.
Unweighted pipeline is estimated at approximately $4.5 billion; weighted pipeline is estimated at $334 million.
A substantial portion of the pipeline is concentrated in a small number of large international government counter-UAS opportunities, each assigned a low estimated probability of award.
The company states pipeline figures are not backlog, booked orders, revenue, or guidance.
Copley Acquisition Corp's shareholders approved extending the deadline to complete a business combination from November 2, 2026 to November 2, 2027, with up to 12 monthly extensions. Holders of 12,889,720 Class A shares redeemed for about $137.1 million, leaving about $46.2 million in the trust account, which matters to shareholders because it reduces the cash backing the remaining shares.
Holders of 12,889,720 Class A shares redeemed at about $10.63 per share, an aggregate of about $137,119,390.16
About $46,241,913.77 remains in the Trust Account and 4,550,280 Class A ordinary shares remain outstanding
Each monthly extension requires a $200,000 deposit into the Trust Account; the first extension runs to December 2, 2026
Sponsor issued an unsecured, non-interest-bearing $2,400,000 promissory note; the vote was 14,428,832 for and 7,101,879 against
Regency Centers reported third quarter 2026 net income attributable to common shareholders of $75.1 million, or $0.41 per diluted share, alongside Nareit FFO of $1.23 per diluted share. The company raised its full-year 2026 Core Operating Earnings guidance midpoint and increased its quarterly common stock dividend by 6% to $0.800 per share. Shareholders experienced higher year-over-year Same Property NOI growth and strong leasing spreads during the quarter.
Reported Q3 2026 Net Income Attributable to Common Shareholders of $75.1 million, or $0.41 per diluted share.
Raised full year 2026 Core Operating Earnings guidance range to $4.65 to $4.67 per diluted share.
Increased quarterly common stock cash dividend by 6% to $0.800 per share.
Same Property NOI increased year-over-year by 5.1% for the third quarter of 2026.
ANI Pharmaceuticals entered a 364-day senior bridge credit facility of up to $676 million with JPMorgan Chase Bank, N.A. as administrative agent. The facility will be used to finance its recommended public cash offer for Egetis Therapeutics shares, convertible loan and warrants, valued at about SEK 5.6 billion, or approximately $559.9 million, and to refinance ANI's existing term loans and some Egetis debt, which adds significant borrowing and secured obligations for ANI shareholders.
Facility allows borrowings up to $676 million and matures 364 days after initial funding
Initial margin of 1.75% for ABR loans and 2.75% for adjusted term SOFR loans
Offer price is SEK 11.25 per Egetis share; total value about SEK 5.6 billion, or $559.9 million
Completion requires holders of at least 90% of Egetis shares (fully diluted) to tender and regulatory clearances; undertakings covering 42.2% of shares expire if the offer is not declared unconditional by March 31, 2027
Change Agents Corporation appointed Chief Strategy Officer Luisa Ingargiola as principal executive officer on November 4, 2026, until it names a new Chief Executive Officer, with no added compensation. The company also issued a $250,000 promissory note to Harllon Holdings LLC with a $75,000 original issue discount, requiring repayment of $325,000 on January 1, 2027, and agreed to issue 150,000 shares to consultants for services.
Luisa Ingargiola, Chief Strategy Officer since June 3, 2026, was appointed principal executive officer on November 4, 2026, and will receive no additional compensation for the role.
Promissory note issued November 4, 2026 to Harllon Holdings LLC: $250,000 principal, $75,000 original issue discount, $325,000 due January 1, 2027.
The note may be prepaid on December 1, 2026 for $312,000.
150,000 shares of common stock agreed to be issued to consultants for services, under the Section 4(a)(2) registration exemption.
Babcock & Wilcox's board approved a dividend of $0.4843750 per share on its 7.75% Series A Cumulative Perpetual Preferred Stock, listed on the NYSE as BW PRA. The record date is December 18, 2026, and the payment date is December 31, 2026. The filing covers only the preferred dividend and contains no results, guidance or other financial figures.
Dividend of $0.4843750 per share on the 7.75% Series A Cumulative Perpetual Preferred Stock
Record date December 18, 2026; payment date December 31, 2026
Preferred stock trades on the New York Stock Exchange under the symbol BW PRA
Tianci International reported fiscal 2026 results for the year ended July 31, 2026, in Exhibit 99.1 to this 8-K. Total revenue rose to $14,242,611 from $9,282,997, helped by $4,409,563 in first-year mineral sales, and the net loss narrowed to $2,454,798 from $2,686,357. Logistics revenue fell 0.7% and its gross profit percentage dropped to 2.29%, so the core business weakened even as total results improved.
Total revenue of $14,242,611 for the year ended July 31, 2026, versus $9,282,997 a year earlier.
Mineral sales, a new business, contributed $4,409,563 at a 7.43% gross profit percentage.
Net loss of $2,454,798 versus $2,686,357 in fiscal 2025; operations used $2,199,382 in cash.
A public offering completed in June 2026 produced net proceeds of $4,390,512.
Brighthouse Financial reported third quarter 2026 net income available to shareholders of $302 million, or $5.21 per diluted share, down from $453 million, or $7.89 per share, a year earlier. Adjusted earnings fell to $527 million, or $9.12 per share, from $970 million, or $16.87 per share, though the company said its annual actuarial review added $314 million of net favorable notable items. The company also said regulatory approvals for the pending $70.00 per share Aquarian Capital acquisition are not expected before the December 6, 2026 Outside Date, and the parties are discussing an extension.
Net income available to shareholders was $302 million, or $5.21 per diluted share, versus $453 million, or $7.89 per share, in the third quarter of 2025.
Adjusted earnings, less notable items, were $213 million, or $3.68 per diluted share, versus $261 million, or $4.54 per share, a year earlier.
Annuity sales were $2.4 billion, including $2.1 billion of Shield Level Annuities, with annuity sales down 12% quarter-over-quarter.
The merger agreement's Outside Date is December 6, 2026; the company and Aquarian Capital are discussing an extension, with no assurance of agreement.
LCI Industries reported third-quarter 2026 results on a call furnished in an 8-K. Net sales were just under $1 billion, down 4% from a year earlier, while adjusted diluted EPS rose to $2.21 from $1.97 and GAAP diluted EPS was $2.05. The company narrowed its full-year adjusted EPS outlook to $8.25 to $8.50 and said the proposed merger with Patrick Industries remains pending.
Q3 2026 net sales were just under $1 billion, down 4% year over year, mainly due to lower North American RV wholesale shipments.
Adjusted diluted EPS was $2.21 versus $1.97 a year earlier; GAAP net income was $50 million, or $2.05 per diluted share.
Full-year 2026 adjusted EPS range was tightened to $8.25 to $8.50; adjusted revenue is expected at $3.9 billion to $4 billion.
The company said it declined a Monomoy Capital proposal because its board judged it not superior to the proposed merger with Patrick Industries.
Tucows reported third-quarter 2026 revenue of $100.0 million, up 1.4% from a year earlier, and a net loss of $10.3 million, down from $23.0 million in the third quarter of 2025. Gross profit and Adjusted EBITDA rose, but the company said gross profit was driven mainly by a large, non-recurring rate adjustment from renegotiating its mobile contract, and cash and restricted cash fell to $41.0 million from $60.2 million at the end of the second quarter.
Revenue of $100.0 million, up 1.4% year over year, driven by revenue growth at Ting.
Net loss of $10.3 million, or $(0.92) per share, versus a net loss of $23.0 million, or $(2.08) per share, in Q3 2025.
Adjusted EBITDA of $18.6 million, up 39.8% year over year, mainly due to the mobile contract re-rate in the Corporate segment.
Cash and restricted cash of $41.0 million at September 30, 2026, down from $60.2 million at June 30, 2026.
Ready Capital reported a third-quarter 2026 GAAP net loss of $62.2 million, or $(0.40) per share, compared with a net loss of $16.7 million, or $(0.13) per share, a year earlier. Distributable loss was $(0.53) per share, and the company declared $0.01 per common share in dividends, down from $0.125 a year earlier, which matters to shareholders because it reflects weaker earnings and a much smaller dividend.
Q3 2026 GAAP loss per common share of $(0.40), versus $(0.13) in Q3 2025; nine-month loss per share of $(2.27)
Distributable loss per common share of $(0.53); before realized losses, $(0.21)
Dividends declared per common share of $0.01 in Q3 2026, versus $0.125 in Q3 2025
Book value of $6.44 per common share as of September 30, 2026; cash of $157 million and total leverage of 2.8x
Diodes reported third quarter 2026 revenue of $532.6 million, up 35.8% from a year earlier, with GAAP net income of $43.7 million, or $0.95 per diluted share, versus $0.31 a year earlier. The company expects fourth quarter revenue of about $550 million, plus or minus 3%, and non-GAAP adjusted EPS of $1.35, plus or minus $0.10. The results are preliminary and unaudited and remain subject to revision until the Form 10-Q is filed.
Q3 2026 revenue $532.6 million, up 35.8% from $392.2 million in Q3 2025
GAAP EPS $0.95 per diluted share vs $0.31 in Q3 2025; non-GAAP EPS $1.18 vs $0.37
Q4 2026 outlook: revenue about $550 million (plus or minus 3%); non-GAAP EPS $1.35 (plus or minus $0.10)
Private placement of 0.00% Convertible Senior Notes due 2031 totaling $375 million
PLAYSTUDIOS reported third-quarter 2026 revenue of $48.9 million, down from $57.6 million a year earlier, and a net loss of $11.0 million, up from $9.1 million. The company discontinued two products, Tetris Block Party and The Win Zone, and recorded $6.7 million in non-cash impairment charges plus a $9.2 million goodwill impairment. It is not providing formal financial guidance, which leaves shareholders without a forward outlook.
Q3 2026 revenue was $48.9 million versus $57.6 million in Q3 2025; direct-to-consumer revenue rose 108% to $16.0 million.
Net loss was $11.0 million versus $9.1 million; Consolidated AEBITDA rose to $10.0 million from $7.2 million.
Goodwill impairment of $9.2 million and a $6.7 million non-cash impairment charge tied to the discontinued products.
No formal financial guidance was provided; restructuring annualized savings range was raised to $37.0 million to $39.0 million, with $44.6 million left on the share repurchase authorization.
VAALCO reported a third-quarter 2026 net loss of $39.8 million ($0.38 per diluted share), compared with net income of $42.4 million in the second quarter, mainly due to $34.7 million of unrealized hedging losses. Net revenue and Adjusted EBITDAX both rose from the second quarter, and the company gave fourth-quarter 2026 sales volume and capital spending guidance.
Q3 2026 net loss of $39.8 million ($0.38 per diluted share) versus Q2 2026 net income of $42.4 million
Net revenue of $147.0 million, up 9% from Q2 2026; Adjusted EBITDAX up 30% to $71.1 million
Q4 2026 guidance: NRI sales volumes of 20,800 to 22,600 BOPD and capital expenditures of $55 million to $75 million
Quarterly dividend of $0.0625 per share payable December 22, 2026; conference call November 6, 2026 at 8:00 a.m. Central Time
Signet Jewelers' subsidiary Sterling Jewelers approved an amended and restated Deferred Compensation Plan on October 30, 2026, effective January 1, 2027. The plan changes how eligible executives can defer pay and how employer contributions vest, and it is disclosed as a compensatory arrangement for named executive officers.
Participants may defer up to 75% of base salary and up to 90% of annual cash bonus.
Employer matches 100% of the first 3% plus 50% of the next 2% of deferred pay; matches made on or after January 1, 2027 vest immediately.
Discretionary employer contributions credited before January 1, 2027 keep a five-year graded vesting schedule.
Eastman Kodak's compensation committee approved higher base salaries and target bonuses for several senior executives, including Chief Financial Officer David Bullwinkle, General Counsel Roger Byrd and Chief Accounting Officer Richard Michaels. The filing also changes how Bullwinkle's and Byrd's annual incentive awards are paid, with 30% of the amount earned to come as restricted stock units. The filing does not describe any company financial results, so the direct effect on shareholders is limited to the cost of higher executive pay.
Byrd's base salary rose to $400,000 and Michaels's to $305,000, effective January 1, 2026, with back pay to be paid in November 2026.
Target annual incentive for Bullwinkle and Byrd is 50% of base salary; for Michaels it is 35%, effective for fiscal 2026 and payable in 2027.
For Bullwinkle and Byrd, 70% of the incentive earned will be paid in cash and 30% in restricted stock units vesting December 31 of the grant year.
Lulu's Fashion Lounge Holdings said its President and Chief Information Officer, Mark Vos, will leave the company when his employment ends on December 31, 2026, at the end of the current term under his employment agreement. The company and Mr. Vos are still discussing possible post-employment consulting and transition terms, and the filing gives no financial results or replacement details.
Mark Vos's employment as President and Chief Information Officer ends December 31, 2026
Agreement to end employment was reached October 30, 2026, and he continues in his role until then
Post-employment consulting services and transition terms remain under discussion
Inspired Entertainment reported third-quarter 2026 revenue of $61.4 million, down 29% from $86.2 million a year earlier, mainly reflecting the November 2025 divestiture of its UK Holiday Parks business; like-for-like revenue rose about 4%. The company also lowered its full-year 2026 Adjusted EBITDA target to $109 million to $112 million from $112 million to $118 million, primarily because Brazil suspended regulated online betting and gaming, a business representing about 5% of revenue.
Q3 2026 revenue was $61.4 million versus $86.2 million a year earlier; like-for-like revenue rose about 4%.
Q3 Adjusted EBITDA was $28.2 million versus $32.3 million, with a record 46% margin versus 37%.
Q3 net loss narrowed to $0.1 million from $1.9 million a year earlier.
FY2026 Adjusted EBITDA outlook is now $109 million to $112 million, down from $112 million to $118 million.
Iovance furnished an updated corporate presentation on November 5, 2026, for use at healthcare conferences and with analysts and stockholders. The presentation gives full-year 2026 revenue guidance of $410 million to $420 million, and its footnote states the midpoint is $55 million, or about 15%, above the previous range of $350 million to $370 million.
Full-year 2026 revenue guidance is $410 million to $420 million, up from a previous range of $350 million to $370 million.
The presentation cites about 80% year-over-year and about 22% quarter-over-quarter revenue growth in third-quarter 2026.
Cash, cash equivalents, short-term investments and restricted cash were about $382 million as of September 30, 2026, with runway stated as well into 2029.
Margin from cost of sales, excluding depreciation and amortization, was about 60% in third-quarter 2026 and 54% year to date.
Strawberry Fields REIT reported third-quarter 2026 results that were pulled down by a $24.6 million foreign currency transaction loss tied to the retirement of Bond Series A, C and D. Net loss was $14.8 million and FFO was negative $3.6 million, compared with net income of $8.9 million and FFO of $20.7 million a year earlier. AFFO, which excludes that loss, rose to $18.8 million, or $0.34 per share, from $18.1 million, or $0.33 per share.
Q3 2026 net loss of $14.8 million vs. net income of $8.9 million in Q3 2025
Q3 2026 FFO of negative $3.6 million ($0.65 per share loss) vs. $20.7 million ($0.37 per share) a year earlier
Q3 2026 AFFO of $18.8 million ($0.34 per share), up from $18.1 million ($0.33 per share)
Subsequent to quarter end on November 1, 2026, the company agreed to buy a 99-bed skilled nursing facility in Angola, Indiana for $15 million
NeOnc reported third-quarter 2026 results, with its net loss falling to $4.4 million from $8.6 million in the year-earlier quarter and total operating expenses declining to $5.8 million from $6.9 million. Cash and cash equivalents rose to $6.2 million at September 30, 2026, helped by a September registered direct offering of approximately $15 million gross, and the company said it will present NEO100 and NEO212 data on November 13, 2026.
Net loss attributable to common stockholders was $7.3 million, or $(0.28) per share, versus $8.6 million, or $(0.45) per share, in Q3 2025; the figure includes $2.8 million of noncash deemed dividends.
Cash and cash equivalents were approximately $6.2 million at September 30, 2026, up from approximately $2.0 million at June 30, 2026.
R&D expenses were $1.3 million, compared with $0.7 million in Q3 2025, while G&A expenses fell to $0.6 million from $0.9 million.
Data from NEO100 and NEO212 will be presented in two posters on November 13, 2026, at the Society for Neuro-Oncology Annual Meeting in Philadelphia.
Strawberry Fields REIT's Board of Directors declared a cash dividend of $0.17 per common share on November 5, 2026. The dividend is payable December 30, 2026, to stockholders of record as of December 16, 2026, and the filing does not compare it with prior dividends.
Cash dividend of $0.17 per common share, declared November 5, 2026
Record date is December 16, 2026; payment date is December 30, 2026
Press release (Exhibit 99.1) describes the declaration as the Q4 2026 cash dividend
CVD Equipment reported third-quarter 2026 revenue of $1.6 million, down 72.1% from a year earlier, and a loss from continuing operations of $2.1 million, or $0.30 per share. The company will no longer pursue new system orders, has cut its workforce further, and has engaged CBRE to sell its Central Islip and Saugerties, New York properties, which matters to shareholders because the core equipment business is winding down while the company holds $23.5 million of cash and no debt.
Q3 2026 revenue was $1.6 million versus $5.7 million in Q3 2025; gross margin was 9.2% versus 32.0%.
Net loss from continuing operations was $2.1 million, or $0.30 per share, including an $0.8 million restructuring charge; income from discontinued operations was $0.6 million.
Cash and cash equivalents were $23.5 million at September 30, 2026, with no outstanding debt.
CBRE, Inc. has been engaged to market the Central Islip and Saugerties, New York properties for sale.
CBRE Services, a wholly-owned subsidiary of CBRE Group, completed a $1 billion offering of senior notes in two $500 million tranches due 2032 and 2037. The Company intends to use the proceeds for general corporate purposes, including repaying commercial paper borrowings and funding the pending acquisition of Onnec Group Limited, which adds debt that shareholders will need to service.
$500 million of 5.650% Senior Notes due January 15, 2032, with semi-annual interest beginning January 15, 2027
$500 million of 5.900% Senior Notes due January 15, 2037, with semi-annual interest beginning January 15, 2027
Notes are fully and unconditionally guaranteed on a senior unsecured basis by CBRE Group, Inc.
Proceeds intended for commercial paper repayment and the pending acquisition of Onnec Group Limited
iSpecimen completed on November 2, 2026, its acquisition of AI software and related assets from Foldlab AI Ltd. for an aggregate price of $4.5 million, paid in cash, milestone payments and stock. The issuance of 2,907,977 shares to Foldlab on November 5, 2026 gives Foldlab approximately 53.6% of the outstanding common stock, a change in control, which means existing shareholders' ownership is substantially diluted.
Purchase price of $4.5 million: $750,000 cash at closing, two $625,000 milestone payments tied to delivery and acceptance, and $2.5 million in stock.
Stock consideration of 2,907,977 shares, based on a $0.8597 volume-weighted average price, issued to Foldlab on November 5, 2026.
Foldlab holds approximately 53.6% of outstanding shares; Zhengkang (Jacob) Shao is its sole director and shareholder.
Shares are subject to a five-year lock-up with no leak-out; stockholders approved the issuance at a special meeting on October 9, 2026.
PodcastOne said it expects record first-half revenue of $31.5 million and Adjusted EBITDA of $3.0 million, up 76% year over year, for the six months ended September 30, 2026. Second-quarter revenue is expected to be $15.2 million with Adjusted EBITDA of $1.4 million. These figures are preliminary, unaudited and subject to change, and the company's board has formed a special committee to evaluate inbound strategic interest, which may or may not lead to a transaction.
Expected first-half revenue of $31.5 million and Adjusted EBITDA of $3.0 million, up 76% year over year
Expected second-quarter revenue of $15.2 million and Adjusted EBITDA of $1.4 million
Special committee of independent directors formed after inbound interest from multiple strategic parties, first announced October 28; company intends to retain a financial advisor
Figures are preliminary and unaudited, not reviewed by MGO; no GAAP net income reconciliation was provided
NextEra Energy filed unaudited pro forma combined financial information and Dominion Energy's financial statements for the pending merger, which was agreed on May 15, 2026. The filing estimates total merger consideration at $62.1 billion, based on NEE's $83.71 closing price on October 30, 2026, and shows lower pro forma per-share earnings than NEE's historical figures. The deal still requires several regulatory approvals and other closing conditions, and the company says the pro forma figures are illustrative only.
Each Dominion Energy share converts into $360 million in aggregate cash, plus 0.8138 NEE shares, pro rata
Estimated merger consideration is $62.1 billion, based on about 738 million NEE shares at $83.71
Pro forma nine-month 2026 basic EPS is $4.16, versus NEE's historical $4.84
Closing requires HSR clearance and approvals from FERC, NRC, and the Virginia, North Carolina and South Carolina regulators
Meta Platforms completed a $15.0 billion offering of five U.S. dollar senior note series maturing from 2031 to 2056, with fixed rates from 5.850% to 7.500%. Underwriters also exercised in full their option to buy 6,000,000 additional Class A common shares from an offering priced in late October 2026, with forward sale agreements covering those shares. The filing does not state how the proceeds will be used, so the added debt and share sales are the main points for shareholders to weigh.
Five senior note series: $3.25 billion due 2031, $3.25 billion due 2033, $4.0 billion due 2036, $1.75 billion due 2046 and $2.75 billion due 2056
Notes were issued under an indenture dated August 9, 2022 with U.S. Bank Trust Company, National Association, as trustee, and a sixth supplemental indenture dated November 5, 2026
Underwriters exercised their option in full on November 4, 2026 for 6,000,000 additional Class A common shares, with additional forward sale agreements on similar terms
Underwriting agreement dated November 3, 2026 with Citigroup Global Markets Inc. and Morgan Stanley & Co. LLC as representatives
Helios Technologies reported third-quarter 2026 net sales of $230 million, up 4% from the prior-year period, and GAAP diluted EPS of $0.53, up 71% from $0.31. The company raised its full-year 2026 sales outlook to $895 million to $902 million from $880 million to $900 million, while narrowing its adjusted EBITDA margin and adjusted diluted EPS ranges.
Q3 2026 net sales were $229.7 million, up 4%; the company cited 13% growth on a pro forma basis
Q3 GAAP diluted EPS was $0.53 versus $0.31; adjusted diluted EPS was $0.80, up 11%
FY2026 sales outlook raised to $895 million to $902 million; adjusted diluted EPS range narrowed to $3.08 to $3.15
Q4 2026 outlook: sales of $205 million to $212 million and adjusted diluted EPS of $0.60 to $0.67
Starling Oncology reported third-quarter 2026 revenue of $169.8 million, up 24.3% from a year earlier, and a net loss of $15.7 million, narrower than $16.5 million a year earlier. The company narrowed its full-year 2026 Adjusted EBITDA guidance and lowered the top end of its revenue and free cash flow ranges, so the outlook is mixed for shareholders.
Q3 2026 revenue was $169.8 million, up from $136.6 million; net loss was $15.7 million versus $16.5 million, or $(0.13) per share versus $(0.14).
Adjusted EBITDA, a non-GAAP measure, was $3.4 million versus $(3.5) million a year earlier.
2026 revenue guidance is now $650 million to $660 million, down from $650 million to $670 million; free cash flow guidance is now $5 million to $10 million, down from $5 million to $15 million.
2026 Adjusted EBITDA guidance narrowed to $4 million to $6 million from $2 million to $7 million; gross profit guidance is now $107 million to $110 million, up at the low end from $105 million.
Turtle Beach reported third-quarter 2026 net revenue of $84.7 million, up 5.3% from $80.5 million a year earlier, and net income of $4.4 million versus $1.7 million. The company reaffirmed its full-year 2026 net revenue guidance of $335 million to $355 million and adjusted EBITDA guidance of $44 million to $48 million, and said it expects capacity to resume share repurchases after the holiday season.
Q3 net revenue was $84.7 million, up 5.3% from $80.5 million; diluted EPS was $0.24 versus $0.08
Adjusted EBITDA was $8.1 million versus $11.0 million a year earlier; gross margin was 34.9%
Full-year 2026 guidance reaffirmed: net revenue $335 million to $355 million, adjusted EBITDA $44 million to $48 million
Nine-month net loss was $18.1 million; inventory rose to $79.8 million, up $23.2 million from the second quarter
Hyperliquid Strategies Inc (PURR) reported net income of $620.6 million for the quarter ended September 30, 2026. The filing says most of that figure came from $803.0 million in net unrealized gains on its HYPE token holdings, and it also included a $172.3 million income tax provision. The company also said it raised $911 million in equity and deployed $802 million, mainly to buy HYPE tokens, and that it has filed an application to become a futures commission merchant.
Net income of $620.6 million for the quarter, including $803.0 million in net unrealized gains on HYPE tokens and a $172.3 million provision for income taxes
Quarter-end HYPE holdings of 38.5 million tokens, up from 29.3 million at June 30, 2026, after 9.1 million tokens were bought for $785 million
Raised $911 million under its committed equity facility and reported $254.6 million in cash and cash-like instruments with zero debt
Stockholders approved on November 4, 2026 the issuance of shares under the ChEF Purchase Agreement above 19.99% of common stock, with 81,436,539 votes for
PROG Holdings' board declared a quarterly cash dividend of $0.14 per share on November 5, 2026. Shareholders of record as of November 17, 2026 will receive the payment on December 1, 2026. The filing contains no earnings, guidance, or other financial results.
Quarterly cash dividend of $0.14 per share declared November 5, 2026
Axon Enterprise announced an incremental minority investment of about $1.2 billion in drone maker Skydio, which it expects will raise Axon's fully diluted ownership from about 15% to about 37%. The primary purchase closed on November 5, 2026, and the remaining transactions are expected to close in the fourth quarter of 2026 and first quarter of 2027. The deal adds a large cash outlay and share issuance for Axon, and Axon also becomes Skydio's exclusive public safety distributor in the U.S. and Canada.
Primary purchase closed November 5, 2026: 25,000,000 Series G preferred shares at $10.19617 per share, for about $254.9 million in aggregate.
Total investment is about $1.2 billion, with about $720 million (approximately 60%) expected in cash and the remainder in Axon common stock.
Axon stock issued for the investment is capped at 19.99% of shares outstanding before the primary closing.
Tender offer to begin within ten business days of the primary closing; the Committed Secondary is expected to close in the first quarter of 2027.
Athene Holding furnished its third-quarter 2026 financial supplement, showing a GAAP net loss available to common stockholder of $1,158 million, compared with net income of $1,223 million a year earlier. Spread related earnings, the company's management measure, fell 3% to $844 million, but rose 7% to $909 million excluding notable items, and the filing says the GAAP loss was tied to large investment and market risk benefit swings. Shareholders face a larger GAAP loss and lower stockholders' equity, while the underlying spread measure was mixed.
GAAP net loss available to Athene common stockholder of $1,158 million in 3Q'26, versus net income of $1,223 million in 3Q'25
Spread related earnings of $844 million, down 3% year over year; excluding notable items, $909 million, up 7%
Total revenues of $3,065 million versus $7,998 million a year earlier, with investment related losses of $3,418 million
Total Athene Holding stockholders' equity was $13,413 million at September 30, 2026, down from $20,492 million at December 31, 2025
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.